Obigen Pharma Inc. (TPEX:7876)
Taiwan · Delayed Price · Currency is TWD 37.30
-1.65 (-4.24%)
At close: May 8, 2026
Obigen Pharma Market Cap
Obigen Pharma has a market cap or net worth of 3.99 billion as of May 8, 2026.
Market Cap
3.99B
Enterprise Value
3.56B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
37.30
Market Cap Chart
Since November 24, 2025, Obigen Pharma's market cap has decreased from 4.62B to 3.99B, a decrease of -13.66%. That is a compound annual growth rate of -27.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 3.99B | -4.36% |
| Dec 31, 2025 | 4.17B | -9.72% |
| Nov 24, 2025 | 4.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 17.55B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.47B |
| Uwell Biopharma | 8.20B |
| Intelligene | 7.40B |
| BIONET Therapeutics | 2.84B |
| Pet Pharm Biotech | 2.73B |
| FullHope Biomedical | 1.12B |
| Han.biomedical | 692.37M |